MASON FISH: Open Payments
NPI 1598342610 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,345 in 199 payments from 19 companies in 2025. Trend: 2023 $3,575 · 2024 $3,306 · 2025 $4,345
Food & beverage: $4,245Education: $100
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 30 | $1,050 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $494 |
| ABBVIE INC. | 20 | $453 |
| E.R. Squibb & Sons, L.L.C. | 14 | $332 |
| Neurocrine BioSciences, Inc. | 24 | $315 |
| Otsuka America Pharmaceutical, Inc. | 17 | $300 |
| Alkermes, Inc. | 10 | $207 |
| Teva Pharmaceuticals USA, Inc. | 14 | $192 |
| Corium, LLC | 6 | $181 |
| Collegium Pharmaceutical, Inc. | 11 | $171 |
Products named: Auvelity, CAPLYTA, VRAYLAR, COBENFY, REXULTI, INGREZZA, Azstarys, ARISTADA.
Industry payments across FL — which companies pay providers there.
